Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression

Journal of Urology

Volumn 195, Issue 1, 2016, Pages 180-187

  Joseph, Richard W ^a   Kapur, Payal ^a   Serie, Daniel J ^a   Parasramka, Mansi ^a   Ho, Thai H ^a   Cheville, John C ^a   Frenkel, Eugene ^a   Parker, Alexander S ^a   Brugarolas, James ^a  

^a MAYO CLINIC   (United States)

Author keywords

biological markers; carcinoma; genes; kidney; mortality; renal cell; tumor suppressor

Indexed keywords

BAP1 PROTEIN; PBRM1 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; BAP1 PROTEIN, HUMAN; NUCLEAR PROTEIN; PBRM1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN THIOLESTERASE;

ADULT; AGGRESSIVENESS; ARTICLE; CANCER RISK; DONKEY; FEMALE; FISHER EXACT TEST; GENE INTERACTION; GENETIC HETEROGENEITY; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; KIDNEY CARCINOMA; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; NEPHRECTOMY; NEPHRON SPARING SURGERY; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SECONDARY ANALYSIS; WILD TYPE; AGED; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETICS; KIDNEY TUMOR; MIDDLE AGED; PROGNOSIS; TUMOR CELL CULTURE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE; YOUNG ADULT;

EID: 84951123969     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2015.07.113     Document Type: Article

References (20)

1. I. Varela, P. Tarpey, K. Raine, and et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma Nature 469 2011 539
2. G. Guo, Y. Gui, S. Gao, and et al. Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma Nat Genet 44 2012 17
3. A.A. Hakimi, I. Ostrovnaya, B. Reva, and et al. Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA Research Network Clin Cancer Res 19 2013 3259
4. L. Gossage, M. Murtaza, A.F. Slatter, and et al. Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma Genes Chromosomes Cancer 53 2014 38
5. C.J. Creighton, M. Morgan, P.H. Gunaratne, and et al. Comprehensive molecular characterization of clear cell renal cell carcinoma Nature 499 2013 43
6. Y. Sato, T. Yoshizato, Y. Shiraishi, and et al. Integrated molecular analysis of clear-cell renal cell carcinoma Nat Genet 45 2013 860
7. G.L. Dalgliesh, K. Furge, C. Greenman, and et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes Nature 463 2010 360
8. S. Pena-Llopis, S. Vega-Rubin-de-Celis, A. Liao, and et al. BAP1 loss defines a new class of renal cell carcinoma Nat Genet 44 2012 751
9. A.S. Parker, J.E. Eckel-Passow, D. Serie, and et al. Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma Eur Urol 66 2014 929
10. P. Kapur, S. Pena-Llopis, A. Christie, and et al. Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation Lancet Oncol 14 2013 159
11. R.W. Joseph, P. Kapur, D.J. Serie, and et al. Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma Cancer 120 2014 1059
12. R. Pawlowski, S.M. Muhl, T. Sulser, and et al. Loss of PBRM1 expression is associated with renal cell carcinoma progression Int J Cancer 132 2013 E11
13. W.H. da Costa, M. Rezende, F.C. Carneiro, and et al. Polybromo-1 (PBRM1), a SWI/SNF complex subunit is a prognostic marker in clear cell renal cell carcinoma BJU Int 113 2014 E157
14. M. Gerlinger, S. Horswell, J. Larkin, and et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing Nat Genet 46 2014 225
15. J. Brugarolas Molecular genetics of clear-cell renal cell carcinoma J Clin Oncol 32 2014 1968
16. R. Mani, R.P. St Onge, J.L. Hartman, and et al. Defining genetic interaction Proc Natl Acad Sci U S A 105 2008 3461
17. S. Peña-Llopis, A. Christie, X.J. Xie, and et al. Cooperation and antagonism among cancer genes: the renal cancer paradigm Cancer Res 73 2013 4173
18. A.E. Krambeck, H. Dong, R.H. Thompson, and et al. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma Clin Cancer Res 13 2007 1749
19. A.S. Parker, B.C. Leibovich, C.M. Lohse, and et al. Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma Cancer 115 2009 2092
20. F.A. Schutz, M.M. Pomerantz, K.P. Gray, and et al. Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study Lancet Oncol 14 2013 81